A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)

Autor: Nishikawa, Kazuhiro, Tsuburaya, Akira, Yoshikawa, Takaki, Kobayashi, Michiya, Kawada, Junji, Fukushima, Ryoji, Matsui, Takanori, Tanabe, Kazuaki, Yamaguchi, Kazuya, Yoshino, Shigefumi, Takahashi, Masazumi, Hirabayashi, Naoki, Sato, Seiji, Nemoto, Hiroshi, Rino, Yasushi, Nakajima, Junta, Aoyama, Toru, Miyagi, Yohei, Oriuchi, Noboru, Yamaguchi, Kensei, Miyashita, Yumi, Morita, Satoshi, Sakamoto, Junichi
Zdroj: In European Journal of Cancer September 2018 101:220-228
Databáze: ScienceDirect
Externí odkaz: